Kunal Amin, DPM
Foot & Ankle Surgery · Fulshear, TXNPI 1558780999
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,087 of the $3,356 with a category attached, or 62.2%. Treace Medical Concepts, Inc. accounts for 75.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $1,630 and has fallen 85.1% since, to $243 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in TX, where the typical reported total is $3,901.
Across 52 payments — averaging $64.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$3K
- Stryker$711
- Organogenesis Inc.$31
- Anika Therapeutics, Inc.$29
- Trimed, Inc.$20
- Paratek Pharmaceuticals, Inc.$18
- plus $28 from 2 others
What the payments were for
- Travel & lodging$2,08762%
- Food & beverage$1,24837%
- Education$201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 19 | $2,519 |
| Stryker | 26 | $711 |
| Organogenesis Inc. | 1 | $31 |
| Anika Therapeutics, Inc. | 2 | $29 |
| Trimed, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $18 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,950
How this compares
$3,356 in reported general payments places this provider in the 45th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 19 | $86 |
| Meloxicam | 20 | $42 |
| Amoxicillin | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fulshear
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.